Integrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
Chondrosarcomas are heterogenous tumours of the bone cartilage and have highly variable prognoses. Here, the authors perform a multi-omics analysis, revealing molecular features that can stratify clinical outcomes.
Enregistré dans:
Auteurs principaux: | Rémy Nicolle, Mira Ayadi, Anne Gomez-Brouchet, Lucile Armenoult, Guillaume Banneau, Nabila Elarouci, Matthias Tallegas, Anne-Valérie Decouvelaere, Sébastien Aubert, Françoise Rédini, Béatrice Marie, Corinne Labit-Bouvier, Nicolas Reina, Marie Karanian, Louis-Romée le Nail, Philippe Anract, François Gouin, Frédérique Larousserie, Aurélien de Reyniès, Gonzague de Pinieux |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/9a7f2546f61d40c9b55be3f258fbc8df |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Curcumin blocks interleukin-1 signaling in chondrosarcoma cells.
par: Thomas Kalinski, et autres
Publié: (2014) -
Primary Extraskeletal Myxoid Chondrosarcoma: A Case Report
par: Renuka Bangalore Nagaraj, et autres
Publié: (2021) -
Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications
par: Yuna Blum, et autres
Publié: (2019) -
Clonal evolution through loss of chromosomes and subsequent polyploidization in chondrosarcoma.
par: Linda Olsson, et autres
Publié: (2011) -
Quantitative SPECT/CT for differentiating between enchondroma and grade I chondrosarcoma
par: Woo Hee Choi, et autres
Publié: (2020)